Amgen

Open: 280.0 Close: 284.16 Change: 4.16

6 lessons that an AI found about Amgen Company Inc Stock after reading internet.

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Inc, estimate, status, stock, company, price, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen Inc. stock outperforms competitors on strong trading day - marketwatch.com.

Today's News

Amgen Inc. stock outperforms competitors on strong trading day - marketwatch.com. Amgen inc. stock outperforms competitors on strong day. Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 78% of the company. 48% of business is held by the top 25 shareholders. General public, who are usually individual investors, hold a 22% stake. HHS Considers Removing J&Js Stelara from Medicare Drug Price Negotiations 11/7/2023 The Department of Health and Human Services in a court filing last week said that the blockbuster treatment could be “deselected” from the drug price negotiation list. Amgen is rated Zacks Rank #3 (Hold) due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates. Amgen reported revenues of $6.9 billion in the last reported quarter, representing a year-over-year change of +3.8% Amgen has raised quarterly dividend by 5.6%. The current Amgen [ AMGN ] share price is $284.16 USD today. Amgen has on average historically risen by 28.3% based on the past 40 years of stock performance. Amgen Ventures typically invests up to $2 to 3 million per company per round with $10m invested over the life of the company. Amgen Medical Science Liaison - Oncology (Madrid) in Madrid, Spain. We are hiring an API Associate Manufacturing Associate in Singapore. Amgen Inc. is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability status. Scam Advisory: Special Advisory: Please be cautious of scam recruitment offers. 70 analysts offering price forecasts for Amgen have a median target of 264.23, with a high estimate of 326.00 and a low estimate of 182.00. Daiwa Securities and BMO Capital Markets upgraded the biopharma firm to an outperform rating. Amgen Inc. is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status or disability status. Please be cautious of scam recruitment offers claiming to be from Amgen.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Inc, estimate, status, stock, company, price, and the most common words in the summary are: amgen, job, stock, best, market, inc, company, . One of the sentences in the summary was: stock outperforms competitors on strong trading day - marketwatch.com.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #job #stock #best #market #inc #company.